---
document_datetime: 2025-01-09 14:39:54
document_pages: 15
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/fluad-tetra-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: fluad-tetra-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 8.6986828
conversion_datetime: 2025-12-28 17:34:03.049888
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Fluad Tetra

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                               | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                 |
|----------------------|---------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------|
| IB/0058              | B.II.b.2.z - Change to importer, batch release arrangements and quality control testing of the FP - Other variation | 06/01/2025                          | n/a                                         |                                  |                                                                                                                         |
| R/0055               | Renewal of the marketing authorisation.                                                                             | 17/10/2024                          | 19/12/2024                                  | SmPC, Labelling and              | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Fluad |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     |                                                                                                                                                                                                                                                                                                         |            |            | PL                     | Tetra in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity.                                                                                                                                                                                                                                                                                             |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0057/G           | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS | 18/11/2024 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| PSUSA/10300 /202403 | Periodic Safety Update EU Single assessment - influenza vaccine (surface antigen, inactivated, adjuvanted)                                                                                                                                                                                              | 03/10/2024 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                             |
| II/0053             | B.I.a.5.a - Changes to the AS of a seasonal, prepandemic or pandemic vaccine against human influenza - Replacement of the strain(s) in a seasonal, prepandemic or a pandemic vaccine against human influenza                                                                                            | 11/07/2024 | 24/07/2024 | SmPC, Labelling and PL | The SmPC section 2 has been updated as follows: - A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022 IVR-238); - A/Thailand/8/2022 (H3N2)-like strain (A/Thailand/8/2022 IVR-237); - B/Austria/1359417/2021 (B/Victoria lineage)-like strain (B/Austria/1359417/2021 BVR-26); - B/Phuket/3073/2013 (B/Yamagata lineage)-like strain (B/Phuket/3073/2013 BVR-1B). The Labelling, PL and Annex A have been updated accordingly. |
| IB/0052             | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                    | 18/04/2024 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                               |

<div style=\"page-break-after: always\"></div>

| IB/0051   | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                         | 16/01/2024   | n/a        |                        |                                                                            |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|----------------------------------------------------------------------------|
| II/0043   | C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one                                                                                                               | 09/11/2023   | 07/12/2023 | SmPC, Labelling and PL | Please refer to Scientific Discussion Fluad Tetra EMEA/H/C/004993/II/0043. |
| IA/0050   | B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place   | 04/12/2023   | n/a        |                        |                                                                            |
| IB/0048   | B.II.b.4.f - Change in the batch size (including batch size ranges) of the finished product - The scale for a biological/immunological medicinal product is increased/decreased without process change (e.g. duplication of line)            | 23/11/2023   | n/a        |                        |                                                                            |
| IA/0049   | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient | 17/11/2023   | n/a        |                        |                                                                            |
| IB/0047/G | This was an application for a group of variations. B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation                                                       | 17/11/2023   | n/a        |                        |                                                                            |

<div style=\"page-break-after: always\"></div>

|                     | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                             |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10300 /202303 | Periodic Safety Update EU Single assessment - influenza vaccine (surface antigen, inactivated, adjuvanted)                                                                                                   | 28/09/2023 | n/a        |                        | PRAC Recommendation - maintenance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| II/0045             | B.I.a.5.a - Changes to the AS of a seasonal, prepandemic or pandemic vaccine against human influenza - Replacement of the strain(s) in a seasonal, prepandemic or a pandemic vaccine against human influenza | 06/07/2023 | 24/07/2023 | SmPC, Labelling and PL | As a result of this variation, Section 2 of the SmPC (qualitative and quantitative composition) has been updated to reflect the changes in influenza strains included in the 2023/2024 formulation. The SmPC section 2 has been updated as follows: • A/Victoria/4897/2022 (H1N1)pdm09-like virus (A/Victoria/4897/2022 IVR-238) • A/Darwin/9/2021 (H3N2)-like virus (A/Darwin/6/2021 IVR-227) • B/Austria/1359417/2021 (B/Victoria Lineage)-like virus (B/Austria/1359417/2021 BVR-26) • B/Phuket/3073/2013 (B/Yamagata Lineage)-like virus (B/Phuket/3073/2013 BVR-1B) The Labelling, package leaflet and Annex A have been updated accordingly. |
| N/0044              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                             | 17/05/2023 | 24/07/2023 | PL                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IB/0042/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                          | 27/04/2023 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

|           | - Changes in the manufacturing process of AS - Minor change in the manufacturing process the AS                                                                                                                                                                                                                                                                                              |            |     | B.I.a.2.a the of     |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------|
| IB/0040/G | This was an application for a group of variations. B.II.b.4.f - Change in the batch size (including batch size ranges) of the finished product - The scale for a biological/immunological medicinal product is increased/decreased without process change (e.g. duplication of line) B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change | 28/03/2023 | n/a | in the manufacturing |
| IB/0041/G | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation                                                | 10/03/2023 | n/a |                      |
| IB/0037/G | This was an application for a group of variations. B.II.b.1.z - Replacement or addition of a manufacturing site for the FP - Other variation B.II.e.6.b - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that does not affect the product information                                                                  | 21/02/2023 | n/a |                      |

<div style=\"page-break-after: always\"></div>

|           | B.II.e.4.c - Change in shape or dimensions of the container or closure (immediate packaging) - Sterile medicinal products                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |     |              |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|--------------|
| IB/0039   | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 03/02/2023 | n/a | of the       |
| II/0036   | B.I.c.1.b - Change in immediate packaging of the AS - Qualitative and/or quantitative composition for sterile and non-frozen biological/immunological ASs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 02/02/2023 | n/a |              |
| IB/0038/G | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 01/02/2023 | n/a | B.II.d.2.a - |

<div style=\"page-break-after: always\"></div>

|                     | product - Minor changes to an approved test procedure B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)   |            |            |             |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------|
| IB/0034             | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation                                                                                                                                                                            | 13/01/2023 | 24/07/2023 | SmPC and PL |                                   |
| IB/0035             | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                | 07/12/2022 | n/a        |             |                                   |
| IB/0033             | B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation                                                                                                                                                                                                                                                | 14/11/2022 | n/a        |             |                                   |
| IA/0032             | B.II.d.1.a - Change in the specification parameters and/or limits of the finished product - Tightening of specification limits                                                                                                                                                                                                                                            | 03/10/2022 | n/a        |             |                                   |
| PSUSA/10300 /202203 | Periodic Safety Update EU Single assessment - influenza vaccine (surface antigen, inactivated, adjuvanted)                                                                                                                                                                                                                                                                | 29/09/2022 | n/a        |             | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| II/0030   | B.I.a.5.a - Changes to the AS of a seasonal, prepandemic or pandemic vaccine against human influenza - Replacement of the strain(s) in a seasonal, prepandemic or a pandemic vaccine against human influenza                                                                                       | 23/06/2022   | 22/07/2022   | SmPC, Labelling and PL   | As a result of this variation, Section 2 of the SmPC (qualitative and quantitative composition) has been updated to reflect the changes in Influenza strains included in the NH 2022/2023 formulation. The virus strains included in the vaccine for the season 2022-2023 are: A/Victoria/2570/2019 (H1N1)pdm09-like virus (A/Victoria/2570/2019 IVR-215); A/Darwin/9/2021 (H3N2)-like virus (A/Darwin/6/2021 IVR- 227); B/Austria/1359417/2021 (B/Victoria lineage)-like virus (B/Austria/1359417/2021 BVR-26); B/Phuket/3073/2013 (B/Yamagata lineage)-like virus (B/Phuket/3073/2013 BVR-1B). Labelling, Package leaflet and Annex A are updated accordingly.   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0029   | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                      | 23/03/2022   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IB/0027   | B.II.z - Quality change - Finished product - Other variation                                                                                                                                                                                                                                       | 25/02/2022   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| II/0021   | B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release/control, and secondary packaging, for biol/immunol medicinal products or pharmaceutical forms manufactured by complex manufacturing processes | 24/02/2022   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IA/0028   | B.I.b.2.a - Change in test procedure for AS or                                                                                                                                                                                                                                                     | 04/02/2022   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

<div style=\"page-break-after: always\"></div>

|           | starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |     |                       |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------|
| IB/0026/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting | 22/12/2021 | n/a | material/intermediate |
| IB/0025   | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 20/12/2021 | n/a |                       |
| IB/0024   | B.I.d.1.c - Stability of AS - Change in the re-test period/storage period or storage conditions - Change to an approved stability protocol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 15/12/2021 | n/a |                       |

<div style=\"page-break-after: always\"></div>

| IB/0023             | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                           | 15/12/2021   | n/a   |                                   |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| IB/0022             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                     | 06/12/2021   | n/a   |                                   |
| IB/0020/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS | 30/11/2021   | n/a   |                                   |
| IA/0019/G           | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites A.7 - Administrative change - Deletion of manufacturing sites                                         | 06/10/2021   | n/a   |                                   |
| PSUSA/10300 /202103 | Periodic Safety Update EU Single assessment - influenza vaccine (surface antigen, inactivated, adjuvanted)                                                                                                                                                                           | 30/09/2021   | n/a   | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| II/0017   | B.I.a.5.a - Changes to the AS of a seasonal, prepandemic or pandemic vaccine against human influenza - Replacement of the strain(s) in a seasonal, prepandemic or a pandemic vaccine against human influenza                                                                       | 08/07/2021   | 23/07/2021   | SmPC, Labelling and PL   | As a result of this variation, Section 2 of the SmPC (qualitative and quantitative composition) has been updated to reflect the changes in Influenza strains included in the NH 2021/2022 formulation. The virus strains included in the vaccine for the season 2021-2022 are: A/Victoria/2570/2019 (H1N1)pdm09-like virus (A/Victoria/2570/2019 IVR-215) A/Cambodia/e0826360/2020 (H3N2)-like virus (A/Cambodia/e0826360/2020 IVR-224 B/Washington/02/2019 (B/Victoria lineage)-like virus (B/Victoria/705/2018 BVR-11) B/Phuket/3073/2013 (B/Yamagata lineage)-like virus (B/Phuket/3073/2013 BVR-1B)   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|--------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0016 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                                             | 19/04/2021   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IB/0015/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a | 14/04/2021   | n/a          |                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

|         | control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place   |            |            |                 | Changes to quality   |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------|----------------------|
| IA/0014 | B.II.f.1.e - Stability of FP - Change to an approved stability protocol                                                                                                                                                                                                                                                                                         | 17/03/2021 | n/a        |                 |                      |
| IB/0012 | B.II.g.5.c - Implementation of changes foreseen in an approved change management protocol - For a biological/immunological medicinal product                                                                                                                                                                                                                    | 08/03/2021 | n/a        |                 |                      |
| IA/0013 | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                   | 01/03/2021 | 23/07/2021 | Annex II and PL |                      |
| IB/0010 | B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate                                                                                                                                                    | 08/02/2021 | n/a        |                 |                      |
|         | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply                                                                                    | 02/02/2021 | n/a        |                 | IB/0007/G            |

<div style=\"page-break-after: always\"></div>

|             | with the Ph. Eur. or with a national pharmacopoeia of a Member State - Excipient/AS starting material                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |     |                   |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------|
| IB/0011     | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 18/01/2021 | n/a |                   |
| II/0008     | C.I.11.b - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Implementation of change(s) which require to be further substantiated by new additional data to be submitted by the MAH assessment is required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 14/01/2021 | n/a | where significant |
| IAIN/0009/G | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites | 20/11/2020 | n/a |                   |

<div style=\"page-break-after: always\"></div>

|           | (excluding manufacturer for batch release) B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                    |            |     |                        |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------|
| IB/0006   | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of                                                                                                                                                                                                                                     | 05/11/2020 | n/a | an obsolete parameter) |
|           | This was an application for a group of variations. B.II.d.1.h - Change in the specification parameters and/or limits of the finished product - Update of the dossier to comply with the provisions of an updated general monograph of the Ph. Eur. for the finished product B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test                                                   | 28/10/2020 | n/a | IB/0005/G procedure    |
| II/0004/G | This was an application for a group of variations. B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Change outside the approved specifications limits range for the AS B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting | 17/09/2020 | n/a |                        |

<div style=\"page-break-after: always\"></div>

|         | material/intermediate B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range   |            |     |
|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| II/0002 | B.II.g.2 - Introduction of a post approval change management protocol related to the finished product                                                                       | 17/09/2020 | n/a |
| IB/0001 | B.II.g.5.c - Implementation of changes foreseen in an approved change management protocol - For a biological/immunological medicinal product                                | 02/09/2020 | n/a |